Cleared Special

K023975 - VOYAGER LINUX

K023975 is an FDA 510(k) clearance for VOYAGER LINUX, manufactured by Z-Kat, Inc.. The device is a Class 2 Neurology device with product code HAW cleared through the Special 510(k) pathway after a 18-day FDA review.

K023975 · Z-Kat, Inc. · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Dec 2002
Decision
18d
Days
Class 2
Risk

K023975 is an FDA 510(k) clearance for the VOYAGER LINUX. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Z-Kat, Inc. (Hollywood, US). The FDA issued a Cleared decision on December 20, 2002 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K023975

510(k) Number K023975 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 02, 2002
Decision Date December 20, 2002
Days to Decision 18 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
131d faster than avg
Panel avg: 149d · This submission: 18d
Pathway characteristics
Modification to existing cleared device.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 413
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K023975.
NAVITRACK SYSTEM TOTAL HIP REPLACEMENT,MODEL 900.200
K022364 · Orthosoft, Inc. · Feb 2003
STRYKER NAVIGATION SYSTEM - HIP MODULE
K022365 · Stryker Instruments · Jan 2003
CATHETER INTRODUCER FOR THE STEALTHSTATION SYSTEM
K022126 · Medtronic Surgical Navigation Technologies · Jan 2003
SMITH & NEPHEW IMAGE GUIDED SURGICAL INSTRUMENTS FOR HIP APPLICATIONS
K021798 · Smith & Nephew, Inc. · Dec 2002
HIP MODULE FOR THE STEALTHSTATION SYSTEM
K021980 · Medtronic Surgical Navigation Technologies · Nov 2002
VECTORVISION CT-FREE KNEE
K021306 · Brainlab AG · Oct 2002
K023975 · VOYAGER LINUX
Download PDF FDA Summary Z-Kat, Inc.